With many years of experience auditing manufacturing facilities throughout India, Greystone is well poised to identify both cGMP API and pharmaceutical manufacturers in India. As has become common knowledge, the cost of manufacturing of pharmaceuticals in India is significantly below that which may be available in Europe and North America. Greystone, with its contacts throughout India will help identify manufacturing sites for your upcoming product launches. Be it beta-lactam products, cytotoxic agents, solid, topical, transdermal, unique packaging requirements or injectable dosage forms, Greystone has the experience to locate the best manufacturer for your needs.

In addition to identifying these sites based on your needs, Greystone is available to conduct on site audits of these facilites to ensure compliance to current good manufacturing practice regulations (both US and ICH). Our India facility contacts are unsurpassed, allowing you to benefit from the lower product costs while maintaining the quality you seek. We audit based on your specific SOPs or use our 'check list' to ensure compliance.

Of course, if you have already identified one or more sites in India for your manufacturing needs, we can audit these site(s) and make cost effective recommendations to you before proceeding. We help the Indian vendors prepare and file DMFs if you prefer that route to registration.

There are no other US based firm with dedicated divisions and our experience that are available to visit your chosen Indian vendors to qualify them on your behalf, to recommend the needed modifications to the vendor and report back to you during the audit as well as provide a written report to you at the conclusion of the site inspection.

Using these unique Greystone services allow you to stay on schedule to registration while avoiding the need for your staff to visit, audit, communicate and report the audit findings to you. This is the best way to take advantage of the reduced costs of Indian site manufacturing, staying on schedule, allowing your staff to concentration on other critical development tasks while aiding in ensureing compliance. Call us for further information.